The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. Five (5) Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.
(PRWEB) March 3, 2010 -- On January 15, 2010, five (5) Cell Processing Facilities: Baylor College of Medicine Center for Cell and Gene Therapy, Beckman Research Institute of City of Hope, Center for Applied Technology Development, Center for Human Cell Therapy Boston, University of Minnesota, Molecular and Cellular Therapeutics Facility, The University of Wisconsin - Madison, Waisman Clinical BioManufacturing Facility and a Coordinating Center, The EMMES Corporation, were each awarded a five year contract. “We are very excited with continuing to support the cell therapy community and implementing new initiatives aimed at advancing the development of new cell therapies,” says NHLBI Project Officer Traci Heath Mondoro, PhD.
The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. The Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.
This morning's announcement detailed a number of PACT’s educational initiatives, which demonstrate PACT’s commitment to the cell therapy community. These initiatives include educational web seminars, workshops and information/education sessions at upcoming scientific conferences.
PACT is currently accepting and evaluating applications. Applications for manufacturing support can be submitted through the PACT website at www.pactgroup.net.
The PACT Group is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel somatic cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at PACT processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT’s educational training focuses on: translational development/scale-up and manufacture of cell therapy products; and quality assurance and regulatory issues.
More information about PACT is available at www.pactgroup.net
PACT, Rockville, MD
Jamie Winestone or Debbie Wood
This project has been funded in whole or in part with Federal funds from the NHLBI, NIH under Contract No. HHSN268201000006C
# # #
Read the full story at http://www.prweb.com/releases/PACTGroup/CellTherapy/prweb3677854.htm.
Copyright©2010 Vocus, Inc.
All rights reserved